PDS Biotechnology Corp 8-K

What Happened PDS Biotechnology Corp (PDSB) filed a Form 8-K on February 23, 2026 to report an update to its corporate presentation deck. The updated presentation is attached to the filing as Exhibit 99.1 and is incorporated by reference under Item 8.01 (Other Events). The filing also lists Exhibit 104 (Cover Page Interactive Data File).

Key Details

• Date of filing: February 23, 2026 (Form 8-K).
• Exhibit included: 99.1 — Corporate Presentation (February 2026).
• Filing Items: Item 8.01 (Other Events) and Item 9.01 (Exhibits); Exhibit 104 (Inline XBRL cover page) also provided.

Why It Matters An updated corporate presentation can contain refreshed information on the company’s strategy, clinical programs, milestones, or investor outlook — material items investors often review before making decisions. The 8-K itself does not report financial results or executive changes; it simply makes the new presentation available. Investors should download and review Exhibit 99.1 for any specific updates that could affect the company’s outlook or valuation.